Nécrose pariétale utérine partielle après capitonnage hémostatique au cours d’une hémorragie de la délivrance

L'hémorragie de la délivrance reste la première cause de mortalité dans la majorité des pays y compris le Maroc. Sa prise en charge doit être multidisciplinaire, rapide, avec mise en 'uvre de moyens médicaux et parfois chirurgicaux pour contrôler l'hémorragie. Les techniques de compression ou de cloisonnement utérins ont été peu évaluées mais diffusées rapidement dans le monde entier vu la facilité de leur réalisation; Néanmoins des complications secondaires ont été rapportées dans la littérature dont la nécrose utérine. Nous rapportons le cas d'une patiente de 33ans césarisée à 38 semaines d'aménorrhée pour utérus cicatriciel associé à une grossesse gémellaire avec inertie utérine. Un capitonnage hémostatique a été nécessaire pour contrôler l'hémorragie, l'évolution a été marquée par la survenue d'une nécrose partielle utérine confirmée histologiquement. Nous insistons à travers cette observation et sous la lumière de la revue de la littérature sur la nécessité d'un suivi post opératoire des patientes qui bénéficient de capitonnage hémostatique pour mieux documenter l'efficacité et les complications de cet acte chirurgical qui reste encore sous évalué.Key words: Hémorragie de la délivrance, Atonie utérine, capitonnage utérin, nécrose utérin

Novel nonsense mutation of BRCA2 gene in a Moroccan man with familial breast cancer

Background: Breast cancer is the most common cancer in women worldwide. About 5 to 10% of cases are due to an inherited predisposition in two major genes, BRCA1 and BRCA2, transmitted as an autosomal dominant form. Male breast cancer is rare and is mainly due to BRCA2 than BRCA1 germline mutations.Objective: Molecular study of BRCA2 gene in man with familial breast cancer.Methods: PCR and direct sequencing of BRCA2 gene.Results: Identification of novel heterozygous germline mutation c.6428C>A ; p.Ser2143Stop of BRCA2 gene.Keywords: male, breast cancer, BRCA2 gene, mutation, genetic counseling

Efficacy of a combination of N-palmitoylethanolamide, beta-caryophyllene, carnosic acid, and myrrh extract on chronic neuropathic pain: A preclinical study

Neuropathic pain (NP) is a common public health problem that poses a major challenge to basic scientists and health-care providers. NP is a complex problem with an unclear etiology and an often-inadequate response to current medications. Despite the high number of drugs available, their limited pharmacological efficacy and side effects hamper their chronic use. Thus, the search for novel treatments is a priority. In addition to pharmaceuticals, natural extracts and food supplements are often used to help treating patients with NP. One such supplement is Noxiall®, a commercially available combination of N-Palmitoylethanolamide (PEA), beta-caryophyllene; carnosic acid and myrrh. Here, we compare the efficacy of Noxiall® to that of the medications gabapentin and pregabalin in the NP model of chronic constriction injury (CCI) using sciatic nerve ligation in mouse. Following CCI, mice developed a significant increase in mechanical allodynia and thermal hyperalgesia. Results showed that administration of either Noxiall®, pregabalin, or gabapentin significantly attenuated mechanical allodynia. The magnitude of the Noxiall® effect was comparable to that of gabapentin or pregabalin. In addition, co-administration of non-effective doses of pregabalin and Noxiall® resulted in a significant decrease in NP, suggesting an additive efficacy. Noxiall® was efficacious also in reducing CCI-induced thermal hyperalgesia. These findings support the rationale of using natural remedies in conjunction with classical pharmacological agents to treat chronic NP

AN INNOVATIVE STRATEGY BASED ON UNCERTAINTY PROFILE FOR THE VALIDATION OF MICROBIOLOGICAL METHODS FOR COUNTING ENTEROBACTERIACEAE IN FOODS

Objective: A new and powerful statistical approach known as the uncertainty profile concept has been suggested for both testing the validity and making easy and straightforward interpretation of results obtained during the validation of an analytical method. The main goal of this paper is to confirm the applicability of this new strategy for the validation of a commercial kit, microbiological method, for the enumeration of the Enterobacteriaceae in foods and the estimate of the measurement uncertainty by using the newly provided formula and without referring to any additional experiments.Methods: An innovative formula to assess the uncertainty by using validation data and without recourse to other additional experiments was proposed. The uncertainty was evaluated through the two-sided β-content, γ-confidence tolerance interval, which is computed with three manners: the Mee's approach, the Generalized Pivotal Confidence, and the Modified Large Simple procedureResults: After the use of the three chemometric method of calculation of tolerance intervals, the obtained results with uncertainty profile show without doubt that the enumeration method is valid over the range of target values given that the upper and the lower 66.7 %-content, 90 %-confidence tolerance limits have fallen within the two acceptance limits of±0.25 Log unit. If the β is stretched to 80 %-content, 90 %-confidence, the three computed tolerance intervals lead to different decisions.Conclusion: we have demonstrated the ability of the uncertainty profile to be used for testing the validity of enumeration method which represents the first application of an uncertainty profile to food microbiological methods, and provides good estimations of the uncertainty measurements for each concentration level.Keywords: Validation, Uncertainty profile, β-content-γ-confidence tolerance interval, Uncertainty measurement, Microbiological metho

The Response of the Honey Bee Gut Microbiota to Nosema ceranae Is Modulated by the Probiotic Pediococcus acidilactici and the Neonicotinoid Thiamethoxam.

The honey bee Apis mellifera is exposed to a variety of biotic and abiotic stressors, such as the highly prevalent microsporidian parasite Nosema (Vairimorpha) ceranae and neonicotinoid insecticides. Both can affect honey bee physiology and microbial gut communities, eventually reducing its lifespan. They can also have a combined effect on the insect's survival. The use of bacterial probiotics has been proposed to improve honey bee health, but their beneficial effect remains an open question. In the present study, western honey bees were experimentally infected with N. ceranae spores, chronically exposed to the neonicotinoid thiamethoxam, and/or supplied daily with the homofermentative bacterium Pediococcus acidilactici MA18/5M thought to improve the honey bees' tolerance to the parasite. Deep shotgun metagenomic sequencing allowed the response of the gut microbiota to be investigated with a taxonomic resolution at the species level. All treatments induced significant changes in honey bee gut bacterial communities. Nosema ceranae infection increased the abundance of Proteus mirabilis, Frischella perrara, and Gilliamella apicola and reduced the abundance of Bifidobacterium asteroides, Fructobacillus fructosus, and Lactobacillus spp. Supplementation with P. acidilactici overturned some of these alterations, bringing back the abundance of some altered species close to the relative abundance found in the controls. Surprisingly, the exposure to thiamethoxam also restored the relative abundance of some species modulated by N. ceranae. This study shows that stressors and probiotics may have an antagonistic impact on honey bee gut bacterial communities and that P. acidilactici may have a protective effect against the dysbiosis induced by an infection with N. ceranae